跳至主要内容
临床试验/NCT05048459
NCT05048459进行中(未招募)不适用

Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer With No Evidence of Disease on Post-Treatment Imaging

Memorial Sloan Kettering Cancer Center2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
40
试验地点
2
主要终点
Progression-Free Survival (PFS)

研究概览

简要总结

The purpose of this study is to compare standard surveillance with telemedicine surveillance (tele-surveillance) and find out which surveillance approach is best for people with HPV-associated head and neck cancer who have no evidence of disease after treatment. The researches will look at how the two approaches affect participants' quality of life, health outcomes, and expenses (for example, costs of routine visits and procedures). They will also determine doctors' and patients' satisfaction with tele-surveillance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pathologically (histologically or cytologically) diagnosis of HPV associated squamous cell carcinoma of the oropharynx (tonsil, base of tongue, or oropharyngeal walls)
  • No evidence of disease on post-treatment PET/CT within 9 months of completing radiation therapy. No evidence of disease is a consensus determination by the patient's radiation, medical, and surgical oncologist. If the first PET/CT is equivocal, then a second PET/CT can be obtained within 9 months of completing radiation therapy.
  • Post-treatment diagnostic imaging with either CT or MRI (recommended but not required)
  • Able to speak and read English fluently
  • Able to provide informed consent

排除标准

  • Patients on clinical trials related to head and neck cancer that have protocol defined follow up activities
  • Incomplete response or recurrent disease on post-treatment PET/CT
  • Completion of radiation and chemotherapy more than 9 months ago

研究组 & 干预措施

Standard surveillance

Active Comparator

This surveillance approach involves the participant coming to the clinic for in-person follow-up visits and having routine endoscopy and cancer imaging procedures as needed

干预措施: Standard surveillance (Other)

Standard surveillance

Active Comparator

This surveillance approach involves the participant coming to the clinic for in-person follow-up visits and having routine endoscopy and cancer imaging procedures as needed

干预措施: Questionnaires (Other)

Telemedicine surveillance (tele-surveillance)

Experimental

Tele-surveillance involves the participant staying at home while their healthcare providers follow their condition and give them the care they need. They can communicate with their healthcare team through face-to-face video conferencing on their desktop computer, laptop, smart phone, or tablet. They can also communicate with their healthcare team by phone.

干预措施: Telemedicine surveillance (tele-surveillance) (Other)

Telemedicine surveillance (tele-surveillance)

Experimental

Tele-surveillance involves the participant staying at home while their healthcare providers follow their condition and give them the care they need. They can communicate with their healthcare team through face-to-face video conferencing on their desktop computer, laptop, smart phone, or tablet. They can also communicate with their healthcare team by phone.

干预措施: Questionnaires (Other)

结局指标

主要结局

Progression-Free Survival (PFS)

时间窗: 2 years

PFS will be defined as pathologic evidence of local or distant tumor progression or death from any cause. Patients

次要结局

  • Locoregional recurrence (LRR)(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验